Bremelanotide at the International Sexologists Conference

A recent article in the German online mag Spiegel.de discusses Palatin's presentation of Bremelanotide at a recent International Conference of Sexologists.

The writer follows a researcher who is developing another new drug to enhance sexual arousal and describes what happened when Palatin presented the results of Bremelanotide to the experts in that field.

The article follows George Dodd, a 63 year old Irishman biochemist...


UPDATE: The product associated with George Dodd's research has been made available for purchase as a "Libido Patch" (click for more information).


Before studying biochemistry at Oxford University, Dodd completed a training program as a perfume maker and has now designed a brand new molecule that resembles dopamine - the substance that occurs naturally in the brain and is associated with feelings of pleasure.

His development is meant to "entice the brain into thinking that it's time for sex". But its action on a person is gentle compared to how he later discovered Bremelanotide works...

Dodd's aphrodisiac is an aroma that is supposed to be inhaled repeatedly over a 24-hour period if possible. And another difference between Bremelanotide (or PT-141 as it was originally called) and Dodd's invention is the aroma's relative instability. It "attaches" itself only briefly and gently and then either disintegrates or is discarded.

He attended the International Conference of Sexologists in Lisbon's Marriott Hotel for a four day meeting of the world's leading experts on sex, in part because he was interested in finding out what his competition is up to....


The Bremelanotide presentation by Palatin happened very early in the morning and included Jim Pfaus, the professor of behavioral research at Concordia University in Montreal and tested the drug initial on rats. (Also mentioned in our last article: "Bremelanotide's PT-141 Test Results")

The article states PT-141 "isn't gentle and it isn't intended to merely lightly stimulate the olfactory system. Instead, the spray quickly enters the bloodstream and is ferried directly into the brain."

It also described Bremelanotide as working "alarmingly well" and said the mood in the conference room became very solemn as the fact were presented. The attending endocrinologists, gynecologists, biochemists and the andrologists (and other "ologists") began to realize this new drug may very well be an aphorodisiac that actually works. And may spell the beginnings of a third sexual revolution.

The audience also included a few sex therapists psychologists who apparently asked very critical questions about Bremelanotide - about its social context and the purpose of such a drug.

However the article states the Palatin presenters were very well prepared and promoted the therapeutic benefits. They also claimed it wasn't a "party drug" and that it should be administered as part of a "carefully designed program of psychotherapy"...


At the time of this conference, Bremelanotide had been tested on more than 1,000 human subjects. The neutral, third-party companies used a double-blind, placebo-controlled experiment. And according to Jim Pfaus, 72 percent of the women tested experienced a sensation of general arousal, while 67 percent reported a significant increase in their sexual appetite. (I've read that Viagra is effective with 50% of males, as a comparison)

Research so far has cost Palatin Technologies about $150 million.


Pfaus also mentioned a few unofficial testimonials from an earlier test phase. In that session of tests, older subjects claimed to have had sex several times in a row after using the nasal spray and women raved about sudden attacks of sexual desire.

The subject of this article, George Dodd, was both impressed and perhaps a little disheartened by the impressive results of the Bremelanotide experiments. Especially since his own product would be in direct competition. However he apparently met up with a Palatin Technologies rep or two and they discussed their research amicably.


Although neither of the two products is available to the general public quite yet, there is one other "aphrodisiac" that relies on smell and is available for purchase.

Many of you may have heard or read about Pheromones which, at least in part, is what drives male dogs crazy when nearby female dogs go into "heat" (ready to mate).

Well humans are not so far removed from that process, although our sense of smell is far less than attune compared to dogs, and (perhaps just as importantly) we remove or cover up a lot of our pheromone "scent" as a result of regular washing and wearing clothes.

Personally I wasn't too sure how reliable Pheromone products would be. Do they genuinely work or are they just a waste of money and time...?

But recently I stumbled upon a few tests and studies that ranked one Phermone product as being the top of the line and there's even a University study that proved its effects. Men who tested the Pheromone product actually reported vastly improved incidents of flirting and even "hooking up" compared to the men who were in the placebo group.

The product in question is called Pherlure and their site is chock full of news and magazine reports from where it was tested and verified.

They have links to media coverage from MSNBC, CNN, Time Magazine, WebMD, as well as a link (just a little ways down from the top) from The University of Illinois - Chicago that states "Novel human pheromone formulation (Di-Dehydroepiandrosterone) increases sexual attractiveness."

So while you're waiting for Bremelanotide to be available on your store shelves, you might want to consider doing your own experiment with Pherlure by clicking here. :)